AAPL343.17-4.56 (-1.31%) ▼|ABBV288.70+3.10 (+1.08%) ▲|ABT104.34+0.64 (+0.62%) ▲|ACN250.68+1.31 (+0.52%) ▲|ADBE261.87-1.96 (-0.74%) ▼|AMAT382.31+5.07 (+1.34%) ▲|AMD518.10+1.31 (+0.25%) ▲|AMGN449.29+10.03 (+2.28%) ▲|AMT190.50+1.53 (+0.81%) ▲|AMZN250.30+2.30 (+0.93%) ▲|AVGO326.13+4.45 (+1.38%) ▲|AXP317.16+3.94 (+1.26%) ▲|BA187.98-0.37 (-0.19%) ▼|BAC51.24+0.68 (+1.34%) ▲|BKNG154.60-1.23 (-0.79%) ▼|BLK1,133.45+15.20 (+1.36%) ▲|BMY61.69+0.21 (+0.34%) ▲|BNY147.92+3.28 (+2.26%) ▲|BRK-B545.14+2.95 (+0.54%) ▲|C122.56+1.94 (+1.61%) ▲|CAT685.18-0.19 (-0.03%) ▼|CL94.03-0.02 (-0.02%) ▼|CMCSA22.44-0.26 (-1.12%) ▼|COF204.39+3.05 (+1.51%) ▲|COP150.40-0.41 (-0.27%) ▼|COST1,014.90+11.58 (+1.15%) ▲|CRM248.19-0.39 (-0.15%) ▼|CSCO108.72+2.22 (+2.08%) ▲|CVS94.48+1.01 (+1.08%) ▲|CVX232.24-0.97 (-0.42%) ▼|DE631.72-14.43 (-2.23%) ▼|DHR232.83+2.33 (+1.01%) ▲|DIS112.06-0.46 (-0.41%) ▼|DUK125.19+0.21 (+0.17%) ▲|EMR162.17+0.58 (+0.36%) ▲|FDX303.68+4.96 (+1.66%) ▲|GD355.16+5.80 (+1.66%) ▲|GE288.64+3.00 (+1.05%) ▲|GEV830.21+15.21 (+1.87%) ▲|GILD159.23+3.19 (+2.04%) ▲|GM76.75+0.83 (+1.09%) ▲|GOOG317.09-0.19 (-0.06%) ▼|GOOGL320.15-0.06 (-0.02%) ▼|GS893.84+18.16 (+2.07%) ▲|HD321.62+1.79 (+0.56%) ▲|HON220.34-0.81 (-0.36%) ▼|IBM255.54+1.98 (+0.78%) ▲|INTC87.42+0.46 (+0.53%) ▲|INTU342.94-0.45 (-0.13%) ▼|ISRG458.00+5.71 (+1.26%) ▲|JNJ270.14+6.33 (+2.40%) ▲|JPM336.17+4.59 (+1.38%) ▲|KO92.20-0.51 (-0.55%) ▼|LIN510.11+1.28 (+0.25%) ▲|LLY1,284.44+10.98 (+0.86%) ▲|LMT621.74+17.56 (+2.91%) ▲|LOW200.44+1.76 (+0.88%) ▲|LRCX236.13+6.03 (+2.62%) ▲|MA618.17-5.43 (-0.87%) ▼|MCD252.42+3.96 (+1.59%) ▲|MDLZ63.23-0.58 (-0.90%) ▼|MDT95.57+0.16 (+0.17%) ▲|META636.28-6.34 (-0.99%) ▼|MMM174.40+0.94 (+0.54%) ▲|MO73.81-0.50 (-0.67%) ▼|MRK144.38-0.89 (-0.61%) ▼|MS184.10+4.61 (+2.57%) ▲|MSFT526.66+2.15 (+0.41%) ▲|MU888.06+10.51 (+1.20%) ▲|NEE82.68+0.58 (+0.70%) ▲|NFLX65.29-0.57 (-0.86%) ▼|NKE38.28+0.98 (+2.61%) ▲|NOW157.54-1.42 (-0.89%) ▼|NVDA214.72+3.76 (+1.78%) ▲|ORCL126.40+0.24 (+0.19%) ▲|PEP137.09+1.32 (+0.97%) ▲|PFE30.12+0.09 (+0.28%) ▲|PG160.93-0.09 (-0.06%) ▼|PLTR195.94-0.82 (-0.41%) ▼|PM202.91+3.44 (+1.72%) ▲|QCOM176.91+1.00 (+0.57%) ▲|RTX194.88+3.87 (+2.03%) ▲|SBUX103.05+2.25 (+2.23%) ▲|SCHW90.79+0.21 (+0.23%) ▲|SO92.81-0.08 (-0.09%) ▼|SPG213.24+1.61 (+0.76%) ▲|T21.06+0.13 (+0.60%) ▲|TMO681.35+7.53 (+1.12%) ▲|TMUS144.85-1.69 (-1.15%) ▼|TSLA393.83+21.61 (+5.80%) ▲|TXN285.58+0.89 (+0.31%) ▲|UBER66.80+0.10 (+0.15%) ▲|UNH419.82+1.73 (+0.41%) ▲|UNP294.92+2.05 (+0.70%) ▲|UPS101.05-0.01 (-0.01%) ▼|USB60.20+0.62 (+1.04%) ▲|V405.73-2.19 (-0.54%) ▼|VZ43.53-1.14 (-2.54%) ▼|WFC83.75+1.36 (+1.64%) ▲|WMT121.48+1.59 (+1.33%) ▲|XOM182.82-0.39 (-0.21%) ▼|AAPL343.17-4.56 (-1.31%) ▼|ABBV288.70+3.10 (+1.08%) ▲|ABT104.34+0.64 (+0.62%) ▲|ACN250.68+1.31 (+0.52%) ▲|ADBE261.87-1.96 (-0.74%) ▼|AMAT382.31+5.07 (+1.34%) ▲|AMD518.10+1.31 (+0.25%) ▲|AMGN449.29+10.03 (+2.28%) ▲|AMT190.50+1.53 (+0.81%) ▲|AMZN250.30+2.30 (+0.93%) ▲|AVGO326.13+4.45 (+1.38%) ▲|AXP317.16+3.94 (+1.26%) ▲|BA187.98-0.37 (-0.19%) ▼|BAC51.24+0.68 (+1.34%) ▲|BKNG154.60-1.23 (-0.79%) ▼|BLK1,133.45+15.20 (+1.36%) ▲|BMY61.69+0.21 (+0.34%) ▲|BNY147.92+3.28 (+2.26%) ▲|BRK-B545.14+2.95 (+0.54%) ▲|C122.56+1.94 (+1.61%) ▲|CAT685.18-0.19 (-0.03%) ▼|CL94.03-0.02 (-0.02%) ▼|CMCSA22.44-0.26 (-1.12%) ▼|COF204.39+3.05 (+1.51%) ▲|COP150.40-0.41 (-0.27%) ▼|COST1,014.90+11.58 (+1.15%) ▲|CRM248.19-0.39 (-0.15%) ▼|CSCO108.72+2.22 (+2.08%) ▲|CVS94.48+1.01 (+1.08%) ▲|CVX232.24-0.97 (-0.42%) ▼|DE631.72-14.43 (-2.23%) ▼|DHR232.83+2.33 (+1.01%) ▲|DIS112.06-0.46 (-0.41%) ▼|DUK125.19+0.21 (+0.17%) ▲|EMR162.17+0.58 (+0.36%) ▲|FDX303.68+4.96 (+1.66%) ▲|GD355.16+5.80 (+1.66%) ▲|GE288.64+3.00 (+1.05%) ▲|GEV830.21+15.21 (+1.87%) ▲|GILD159.23+3.19 (+2.04%) ▲|GM76.75+0.83 (+1.09%) ▲|GOOG317.09-0.19 (-0.06%) ▼|GOOGL320.15-0.06 (-0.02%) ▼|GS893.84+18.16 (+2.07%) ▲|HD321.62+1.79 (+0.56%) ▲|HON220.34-0.81 (-0.36%) ▼|IBM255.54+1.98 (+0.78%) ▲|INTC87.42+0.46 (+0.53%) ▲|INTU342.94-0.45 (-0.13%) ▼|ISRG458.00+5.71 (+1.26%) ▲|JNJ270.14+6.33 (+2.40%) ▲|JPM336.17+4.59 (+1.38%) ▲|KO92.20-0.51 (-0.55%) ▼|LIN510.11+1.28 (+0.25%) ▲|LLY1,284.44+10.98 (+0.86%) ▲|LMT621.74+17.56 (+2.91%) ▲|LOW200.44+1.76 (+0.88%) ▲|LRCX236.13+6.03 (+2.62%) ▲|MA618.17-5.43 (-0.87%) ▼|MCD252.42+3.96 (+1.59%) ▲|MDLZ63.23-0.58 (-0.90%) ▼|MDT95.57+0.16 (+0.17%) ▲|META636.28-6.34 (-0.99%) ▼|MMM174.40+0.94 (+0.54%) ▲|MO73.81-0.50 (-0.67%) ▼|MRK144.38-0.89 (-0.61%) ▼|MS184.10+4.61 (+2.57%) ▲|MSFT526.66+2.15 (+0.41%) ▲|MU888.06+10.51 (+1.20%) ▲|NEE82.68+0.58 (+0.70%) ▲|NFLX65.29-0.57 (-0.86%) ▼|NKE38.28+0.98 (+2.61%) ▲|NOW157.54-1.42 (-0.89%) ▼|NVDA214.72+3.76 (+1.78%) ▲|ORCL126.40+0.24 (+0.19%) ▲|PEP137.09+1.32 (+0.97%) ▲|PFE30.12+0.09 (+0.28%) ▲|PG160.93-0.09 (-0.06%) ▼|PLTR195.94-0.82 (-0.41%) ▼|PM202.91+3.44 (+1.72%) ▲|QCOM176.91+1.00 (+0.57%) ▲|RTX194.88+3.87 (+2.03%) ▲|SBUX103.05+2.25 (+2.23%) ▲|SCHW90.79+0.21 (+0.23%) ▲|SO92.81-0.08 (-0.09%) ▼|SPG213.24+1.61 (+0.76%) ▲|T21.06+0.13 (+0.60%) ▲|TMO681.35+7.53 (+1.12%) ▲|TMUS144.85-1.69 (-1.15%) ▼|TSLA393.83+21.61 (+5.80%) ▲|TXN285.58+0.89 (+0.31%) ▲|UBER66.80+0.10 (+0.15%) ▲|UNH419.82+1.73 (+0.41%) ▲|UNP294.92+2.05 (+0.70%) ▲|UPS101.05-0.01 (-0.01%) ▼|USB60.20+0.62 (+1.04%) ▲|V405.73-2.19 (-0.54%) ▼|VZ43.53-1.14 (-2.54%) ▼|WFC83.75+1.36 (+1.64%) ▲|WMT121.48+1.59 (+1.33%) ▲|XOM182.82-0.39 (-0.21%) ▼|
11 C
New York
Monday, October 26, 2026

Tag: patients

newsFORsourcecompanycontentinformation1releasesmarket

Kelun-Biotech Announces Approximately US$250 Million Placement

CHENGDU, China, June 5, 2025 /PRNewswire/ -- On June 5, 2025, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced the placement of...

Pantai Hospital Kuala Lumpur Advances Adult Congenital Heart Care with First Minimally Invasive PDA Device Closure

KUALA LUMPUR, Malaysia, June 6, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) marked a significant milestone in cardiovascular care with the successful transcatheter...

ZEISS CLARUS 700 Receives NMPA Approval in China

ZEISS Medical Technology expands retinal insights for ophthalmologists with ultra-widefield, high-resolution imaging capabilities JENA, Germany and SHANGHAI, June 5, 2025 /CNW/ -- ZEISS Medical Technology announced...

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 (the “notes”). The Offering is expected to close on June 12, 2025, subject to customary closing conditions.

Friedreich’s Ataxia Market Poised for Rapid Expansion During the Forecast Period (2025-2034) as Drug Pipeline Gains Momentum | DelveInsight

The dynamics of the Friedreich's ataxia market are anticipated to change as companies across the globe are thoroughly working toward the development of new...

The Inner Circle acknowledges, Dr. Jeremy A. Scarlett as a Pinnacle Professional Member

SHEBOYGAN, Wis., June 5, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Jeremy A. Scarlett is acknowledged as a Pinnacle Professional Member Inner...

Kyivstar Group Reports First Quarter 2025 Financial Results in Conjunction with its Nasdaq Listing Process

KYIV, Ukraine, June 5, 2025 – Kyivstar Group, Ukraine’s leading digital operator (“Kyivstar Group” or “the Company”) and a subsidiary of VEON Ltd. (Nasdaq: VEON) (“VEON Group” or “VEON”), today announced its unaudited financial and operating results for the first quarter ended March 31, 2025.

Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that   Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference.

AACN Launches Nursing Workforce Solutions Program at 25 Hospitals

American Association of Critical-Care Nurses introduces 18-month nurse leadership and innovation training program supported by Johnson & Johnson ALISO VIEJO, Calif., June 5, 2025 /PRNewswire/...

ImPact Biotech Announces Treatment of First Patient in Phase 1 Clinical Trial of Padeliporfin VTP in Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (PDAC)

–  Previously inoperable patient converted to eligible for resection, underwent pancreaticoduodenectomy, following single course of treatment with Padeliporfin VTP  –

Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

NEW HAVEN, Conn., June 5, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for...

TerThera reached GMP status for their Terbium-161 product, improving clinical access by meeting the highest quality standards.

GMP TERBIUM-161 PRODUCT LAUNCHED BY TERTHERA BREDA, Netherlands, June 5, 2025 /PRNewswire/ -- TerThera B.V. has officially launched the world's first GMP-compliant Terbium-161 NCA, setting...

AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™

AVITA Medical announces the first clinical publication of Cohealyx, demonstrating significantly faster wound bed vascularization and autograft readiness.

AMGEN TO PRESENT AT GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif., June 5, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Goldman Sachs 46th Annual Global Healthcare Conference at 9:20 a.m. PT on Tuesday,...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatients

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers